PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsNext-generation genomic research platform launched in the UK for COVID-19

BioNews

Next-generation genomic research platform launched in the UK for COVID-19

Published 3 July 2020 posted in News and appears in BioNews 1054

Author

Dr Nicoletta Charolidi

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.

Genomics England has launched a new, secure, data-processing platform for global COVID-19 genomic research...

Genomics England has launched a new, secure, data-processing platform for global COVID-19 genomic research.

Partnering with a biomedical data processing start-up and a web services company, Genomics England has generated a virtual environment that will allow medical researchers and biopharma from around the world to access and analyse patient genomics data. 

The first project for the platform will be to analyse data to aid the COVID-19 response. The goal is to decipher individual responses to the pandemic and test the flexibility of genomic data through the platform's analytics capability. The platform will also access the 100,000 Genomes Project data to ultimately help understanding cancers and rare diseases.

Chris Wigley, CEO at Genomics England, said 'this is all about impact for patients in the UK and beyond, who will benefit from Genomic England's support for the response to this terrible pandemic. By improving understanding of why some patients have such severe responses to the virus while others have a mild response, Genomics England is helping to support vaccine and drug development. This will ultimately ensure that the treatment of the UK's COVID patients is personalised, safer and more effective'.

Working with Genetics of Mortality in Critical Care (GenOMICC) consortium and the NHS, Genomics England will be adding to the comparisons of new whole-genome sequencing data from up to 20,000 COVID-19 intensive care patients, and up to 15,000 people with mild symptoms.

Startup Lifebit designed the platforms which will enable scientists worldwide to analyse large genomic datasets using various applications and to collaborate in real-time in the safe environment of Genomics England. Dr Maria Chatzou Dunford, CEO of Lifebit, said: 'For the first time, we have managed to combine Fort Knox-grade security for participant data with maximum research flexibility. Genomics England sets a precedent on how research platforms should bring computation to the data, rather than the other way around. Now disparate cohorts of large and sensitive data can be analysed by researchers without copying or moving the data, and true collaboration can happen… this rings in an end to the era of risky and unnecessary data transfers.'

Amazon Web Services (AWS) in the meantime will provide the computing power and secure 'cloud' storage infrastructure that will allow multi-user access enabling international collaborations. John Davies, head of the UK and Ireland healthcare for AWS' public sector division, added: 'Using AWS, Genomics England will be able to provide researchers with access to secure, scalable cloud computing resources that will enable them to perform studies to better understand the virus and deliver better outcomes and treatments for NHS patients.'

It is hoped that this innovative platform will allow researchers to discover genetic factors that may explain why some patients are more susceptible to SARS-CoV-2, the virus that leads to COVID-19, or are more severely affected; subsequently identifying those most at risk. Furthermore, this ground-breaking research environment may also aid researchers towards a more rapid development of vaccines and treatments.

Sources and References

  • 29/06/2020
    Genomics England
    Genomics England launches next-generation research platform central to UK COVID-19 response
  • 30/06/2020
    Computer Weekly
    Genomics England taps up AWS and Lifebit to create cloud-based COVID-19 research environment

Related Articles

PET BioNews
Comment
28 June 2021 • 2 minutes read

FILM: Sarah Norcross and Professor Sir Mark Caulfield discuss whole genome sequencing and genomic medicine

by BioNews

A conversation between Sarah Norcross (director of the Progress Educational Trust) and Professor Sir Mark Caulfield (outgoing chief scientist at Genomics England) about the past, present and future of NHS genomics...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
21 May 2021 • 2 minutes read

UK government to develop global standards and policies to share genomic data

by Dr Rachel Montgomery

The UK Government has announced a year-long implementation plan that it hopes will position the UK as a global leader in genomic healthcare...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
28 January 2021 • 1 minute read

UK offers genomic expertise to identify new COVID strains worldwide

by Dr Eleanor Lynam

The UK has offered to use its world-leading expertise in genomics to aid countries that lack the resources to identify evolving variants of the SARS-CoV-2 virus...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
30 October 2020 • 2 minutes read

New vision from the NIH signals a new era for human genomics

by Dr Marieke Bigg

The US National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), has published a strategic vision describing its research priorities and opportunities in human genomics for the coming decade...

PET BioNews
Comment
16 October 2020 • 4 minutes read

National Genomic Healthcare Strategy: a view from Genomics England

by Sarah Chan

Genomics is revolutionising the way we think about healthcare. This is perhaps a bold statement to quote from the National Genomics Healthcare Strategy but one I am fully invested in...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
Comment
15 May 2020 • 2 minutes read

Genomics in an age of COVID-19

by Chris Wigley

COVID-19 has caused unprecedented levels of damage and disruption to the global population and economy, with no current cure or vaccine to prevent it. But, five months after the virus began to spread, there are still many questions that need to be answered...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
27 March 2020 • 1 minute read

UK whole genome sequence alliance to map spread of coronavirus

by Alegria Vaz Mouyal

The UK Government and its chief scientific adviser, Sir Patrick Vallance, have backed research to map how COVID-19 spreads and behaves by using whole genome sequencing...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Breast cancer drug depletes ovarian reserve in mice

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.

Find out how you can advertise here
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
13 June 2022 • 2 minutes read

Drop in diversity of blood stem cells leads to old-age health issues

1 August 2022 • 2 minutes read

First UK medical guidelines issued for trans fertility preservation

1 August 2022 • 2 minutes read

Common virus may be cause of recent hepatitis cases in children

1 August 2022 • 2 minutes read

Male age has more impact on IVF birth rate than previously thought

1 August 2022 • 2 minutes read

CRISPR genome editing treatments may raise cancer risk

1 August 2022 • 2 minutes read

Differences in IVF-conceived children's size disappear by adolescence

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856